✦ LIBER ✦

Safety of Cyclosporin A in HCV-Infected Patients : Experience with Cyclosporin A in Patients Affected by Rheumatological Disorders and Concomitant HCV Infection

✍ Scribed by MAURO GALEAZZI; FRANCESCA BELLISAI; CHIARA GIANNITTI; STEFANIA MANGANELLI; GABRIELLA MOROZZI; GIAN DOMENICO SEBASTIANI

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cyclosporine A for the treatment of auto

✍ Mauro Galeazzi; Francesca Bellisai; Stefania Manganelli; Gabriella Morozzi; Gian 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 125 KB

PA.109 CYCLOSPORINE A FOR THE TREATMENT

✍ R. Manna; M. Granata; A. Migliore; C. Fonnesu; M. Giovinale; A. Soriano; U. Mass 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Safety of the concomitant use of caspofu

✍ Sanz-Rodriguez, C; Lopez-Duarte, M; Jurado, M; Lopez, J; Arranz, R; Cisneros, J- 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 159 KB

Prevalence of rheumatological disease in

✍ Goulding, CA; Albolushi, SS; O'connell, P; Murray, FE 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 157 KB

RHABDOMYOLYSIS TRIGGERED BY CYTOMEGALOVI

✍ Wai-Man Wong; Tony Wai-Hung Shek; Koon-Ho Chan; Elaine Chau; Kam-Chuen Lai 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 571 KB

Long-term safety of anti-TNF-α in PsA pa

✍ Costa, Luisa; Caso, Francesco; Atteno, Mariangela; Giannitti, Chiara; Spadaro, A 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 107 KB